FETO-MATERNAL RISK FACTOR ASSOCIATED TO THE MODERATELY AND EXTREMELY OBESE PREGNANT WOMAN IN COMPARISON TO THE NORMAL WEIGHTED PREGNANT CASES (PRIMIGRAVIDA AND MULTIGRAVIDA CASES): A COMPARATIVE COHORT RESEARCH

Journal Title: Indo American Journal of Pharmaceutical Sciences - Year 2018, Vol 5, Issue 5

Abstract

Objective: The comparison of the adverse Feto-maternal outcomes in both the groups of Normal and overweight pregnant woman was the objective of this particular research. Methods: Design of the research was comparative cohort, which was completed in the time span of November, 2016 to October, 2018 (Mayo Hospital, Lahore) on a sample of 200 gravid ladies. Sample was divided into two main groups named as overweight and normal pregnant women of hundred cases each. Sample was comprised of pregnant women having gestational age in the range of 08 weeks – 40 weeks. Overweight and normal cases were categorized respectively as (BMI 25 – 29.9 Kg/m2) and (BMI of 18.5 – 24.9), normal cases were taken as controls. Feto-maternal outcomes were compared through Chi-square test and the pvalue was taken as (< 0.05). Results: Women selected for the research were in the age bracket of 30 – 45 years with a mean age of (30 ± 4.1 years). High frequency of pre-eclampsia was observed in overweight women in comparison to the normal group (27% vs 9%), gestational diabetes mellitus (DM) (22% vs 5%), PIH (24% vs 8%), Caesarean section (44% vs 16%), prolonged labor (4% vs 6%), Postpartum Hemorrhage (5% vs 2%) and Wound infection (3% vs 2%). The significant P-value was taken as (< 0.001). In terms of fetal complications in both the groups when compared were as Early neonatal death (11% vs 1%), Still birth (13% vs 2%), NICU admission (47% vs 10%) and shoulder dystocia (5% vs 1%). Except the incidence of shoulder dystocia outcomes were statistically significant. Conclusion: It is concluded that deleterious effects are related to the incidence of obesity on the Feto-maternal outcomes. Key Words: Outcomes, Controls, Pregnant Overweight Women and Adverse Feto-maternal.

Authors and Affiliations

Keywords

Related Articles

DEPRESSION- CURRENT APPROACHES FOR ITS CONVENTIONAL AND ALTERNATIVE TREATMENT

Depression is a mood disorder that affects physical and mental health by altering a person’s behaviour, feelings, and thoughts. Multiple neurotransmitters and part of brain (mainly amygdala, the thalamus and the hippocam...

SYNTHESIS OF 2-[2-HYDROXY-5-(3-SUBSTITUTEDIMINO-1, 2, 4- DITHIAZOLO)] AMINO PHENYL INDOLES

2-[2-Hydroxy-5-(-2,4-substituted-dithiobiureto)]phenylindoles with iodine in ethanol as an oxidative cyclising agent was transformed into the 2-[2-hydroxy-5-(3-substitutedimino-1,2,4-dithiazolo)]aminophenylindoles in one...

PREVALENCE OF HEPATITIS B IN THE PATIENT COMING TO PATHOLOGY LABORATORY AT COMBINED MILITARY HOSPITAL (CMH) LAHORE FROM PUNJAB

Introduction; Hepatitis is a swelling or infection of the liver that makes it to stop work properly. Most of the times, viruses are the major cause of hepatitis but drug or alcohol use can also lead to hepatitis. In some...

HERBAL EXTRACT ENCAPSULATED IN CHITOSAN NANOPARTICLE: A NOVEL STRATEGY FOR THE TREATMENT OF UROLITHIASIS

In current study the inhibitory potential of Tridax procumbens leaf extract loading chitosan nanoparticle against calcium oxalate crystallization under in vitro condition. Kidney stone formation was studied using three a...

DEVELOPMENT AND VALIDATION OF UV-SPECTROSCOPIC METHOD FOR THE ESTIMATION OF METFORMIN IN BULK AND PHARMACEUTICAL DOSAGE FORM

A new simple, accurate, rapid, precise, reproducible and cost effective spectrophotometric method for the quantitative estimation of Metformin in bulk and pharmaceutical dosage form. The developed visible spectrophotomet...

Download PDF file
  • EP ID EP292403
  • DOI -
  • Views 266
  • Downloads 0

How To Cite

(2018). FETO-MATERNAL RISK FACTOR ASSOCIATED TO THE MODERATELY AND EXTREMELY OBESE PREGNANT WOMAN IN COMPARISON TO THE NORMAL WEIGHTED PREGNANT CASES (PRIMIGRAVIDA AND MULTIGRAVIDA CASES): A COMPARATIVE COHORT RESEARCH. Indo American Journal of Pharmaceutical Sciences, 5(5), 4317-4323. https://europub.co.uk/articles/-A-292403